Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell
2014 Mar 06;535:700-9. doi: 10.1016/j.molcel.2014.02.015.
Show Gene links
Show Anatomy links
SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.
Keller KE
,
Doctor ZM
,
Dwyer ZW
,
Lee YS
.
???displayArticle.abstract???
Abnormal metabolism and sustained proliferation are hallmarks of cancer. Pyruvate kinase M2 (PKM2) is a metabolic enzyme that plays important roles in both processes. Recently, PKM2 was shown to have protein kinase activity phosphorylating histone H3 and promoting cancer cell proliferation. However, the mechanism and extent of this protein kinase in cancer cells remain unclear. Here, we report that binding of succinyl-5-aminoimidazole-4-carboxamide-1-ribose-5'-phosphate (SAICAR), a metabolite abundant in proliferating cells, induces PKM2's protein kinase activity in vitro and in cells. Protein microarray experiments revealed that more than 100 human proteins, mostly protein kinases, are phosphorylated by PKM2-SAICAR. In particular, PKM2-SAICAR phosphorylates and activates Erk1/2, which in turn sensitizes PKM2 for SAICAR binding through phosphorylation. Additionally, PKM2-SAICAR was necessary to induce sustained Erk1/2 activation and mitogen-induced cell proliferation. Thus, the ligand-induced protein kinase activity from PKM2 is a mechanism that directly couples cell proliferation with intracellular metabolic status.
Anastasiou,
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.
2012,
Pubmed
Bartek,
Checking on DNA damage in S phase.
2004,
Pubmed
Carpenter,
Receptors for epidermal growth factor and other polypeptide mitogens.
1987,
Pubmed
Chang,
Mammalian MAP kinase signalling cascades.
2001,
Pubmed
Chen,
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
2011,
Pubmed
Christofk,
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.
2008,
Pubmed
Chung,
Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation.
2010,
Pubmed
Crews,
Extracellular signals and reversible protein phosphorylation: what to Mek of it all.
1993,
Pubmed
Edelhoch,
Spectroscopic determination of tryptophan and tyrosine in proteins.
1967,
Pubmed
Gao,
Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.
2012,
Pubmed
Gupta,
Human pyruvate kinase M2: a multifunctional protein.
2010,
Pubmed
Hake,
Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis".
2006,
Pubmed
Hanahan,
Hallmarks of cancer: the next generation.
2011,
Pubmed
Hanks,
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
1988,
Pubmed
Haystead,
Ordered phosphorylation of p42mapk by MAP kinase kinase.
1992,
Pubmed
Jeyasingham,
Evaluation of phosphoenolpyruvate as a phosphoryl group donor for phosphoproteins in skeletal muscle.
1998,
Pubmed
Jiang,
PKM2 regulates chromosome segregation and mitosis progression of tumor cells.
2014,
Pubmed
Keller,
SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.
2012,
Pubmed
Khandelwal,
Phosphoenolpyruvate-dependent protein kinase activity in rat skeletal muscle.
1983,
Pubmed
Kim,
Histone variant H3.3 stimulates HSP70 transcription through cooperation with HP1γ.
2011,
Pubmed
Koppenol,
Otto Warburg's contributions to current concepts of cancer metabolism.
2011,
Pubmed
Lee,
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.
2008,
Pubmed
Luo,
Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.
2011,
Pubmed
Luo,
Emerging roles of PKM2 in cell metabolism and cancer progression.
2012,
Pubmed
Mazurek,
Pyruvate kinase type M2: a crossroad in the tumor metabolome.
2002,
Pubmed
Mazurek,
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
2011,
Pubmed
McKnight,
Please keep me 2uned to PKM2.
2014,
Pubmed
Mitrophanov,
Positive feedback in cellular control systems.
2008,
Pubmed
Nilsson,
Cell cycle regulation by the Cdc25 phosphatase family.
2000,
Pubmed
Pearson,
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.
2001,
Pubmed
Postma,
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria.
1993,
Pubmed
Roskoski,
ERK1/2 MAP kinases: structure, function, and regulation.
2012,
Pubmed
Sugden,
Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active.
2011,
Pubmed
Vander Heiden,
Exploiting tumor metabolism: challenges for clinical translation.
2013,
Pubmed
Vander Heiden,
Understanding the Warburg effect: the metabolic requirements of cell proliferation.
2009,
Pubmed
Yang,
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
2011,
Pubmed
Yang,
PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.
2012,
Pubmed
Yang,
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
2012,
Pubmed
